ArticleAdvances in therapy2023

Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain.

Juan Cosin-Sales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.